Corrigendum to:: 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia [Eur Heart J (2017)
Ulf Landmesser,M. John Chapman,Jane K Stock,Pierre Amarenco,Jill J. F. Belch,Jan Borén,Michel Farnier,Brian A. Ference,Stephan Gielen,Ian D. Graham,Diederick E. Grobbee,G. Kees Hovingh,G. Kees Hovingh,Thomas F. Lüscher,Massimo F Piepoli,Kausik K. Ray,Erik S.G. Stroes,Olov Wiklund,Stephan Windecker,José Luis Zamorano,Fausto J. Pinto,Lale Tokgozoglu,Jeroen J. Bax,Alberico L. Catapano +23 more
Reads0
Chats0
About:
This article is published in European Heart Journal.The article was published on 2017-11-24 and is currently open access. It has received 11 citations till now. The article focuses on the topics: Proprotein convertase & Kexin.read more
Citations
More filters
Journal ArticleDOI
2018 Guidelines for the management of dyslipidemia in Korea.
Eun-Jung Rhee,Hyeon Chang Kim,Jae Hyeon Kim,Eun Young Lee,Byung Jin Kim,Eun Mi Kim,YoonJu Song,Jeong Hyun Lim,Hae Jin Kim,Seonghoon Choi,Min Kyong Moon,Jin Oh Na,Kwang-Yeol Park,Mi Sun Oh,Sang Youb Han,Jung Hyun Noh,Kyung Hee Yi,Sang Hak Lee,Soon Cheol Hong,In-Kyung Jeong +19 more
TL;DR: The incidence of coronary artery disease (CAD) is rising in South Korea and although cerebral hemorrhage has declined since 2002, cerebral infarction is on the rise, speculated to be due to the elevated prevalence of dyslipidemia and diabetes mellitus with the growing obesity population.
Journal ArticleDOI
CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?
TL;DR: Evaluating the evidence for the use of LDL subfractions, or LDL-P, when assessing CVD risk in patients for whom PCSK9 inhibitors are considered as a lipid-lowering therapy finds no studies have proven that these measurements improve clinical outcomes.
Journal ArticleDOI
Alirocumab as add-on therapy to statins: current evidence and clinical potential.
Johann Auer,Robert Berent +1 more
TL;DR: Current knowledge about antibody-mediated PCSK9 inhibition as add-on therapy to statin and the clinical potential that may be expected are discussed.
Journal ArticleDOI
The year in cardiology 2017: prevention.
TL;DR: This paper presents a meta-analysis of data from the Danish General Population Study and the German Center of Cardiovascular Research (DZHK) that shows clear trends in mortality and morbidity among patients with a history of heart attack and stroke.
Familial hypercholesterolaemia: a common cause of premature coronary disease in the community and a paradigm for the practice of precision medicine
Jing Pang,Gerald F. Watts +1 more
TL;DR: The science of FH is presented, a review of major advances in the care of Fh in the form of a “how to” guide and an overview of initiatives for closing the worldwide gaps in care are presented.
Related Papers (5)
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))
François Mach,Colin Baigent,Alberico L. Catapano,Konstantinos C. Koskinas,Manuela Casula,Lina Badimon,M J Chapman,G. De Backer,Victoria Delgado,Brian A. Ference,I M Graham,Alison Halliday,Ulf Landmesser,Borislava Mihaylova,Terje R. Pedersen,Gabriele Riccardi,Dimitrios J. Richter,Marc S. Sabatine,Marja-Riitta Taskinen,Lale Tokgozoglu,Olov Wiklund,Djamaleddine Nibouche,Parounak H. Zelveian,Peter Siostrzonek,Ruslan Najafov,P van de Borne,Belma Pojskic,Arman Postadzhiyan,Lambros Kypris,Jindřich Špinar,Mogens Lytken Larsen,Hesham Salah Eldin,Margus Viigimaa,Timo E. Strandberg,Jean Ferrières,Rusudan Agladze,Ulrich Laufs,Loukianos S. Rallidis,Laszlo Bajnok,Thorbjorn Gudjonsson,Vincent Maher,Yaakov Henkin,Michele Massimo Gulizia,Aisulu Mussagaliyeva,Gani Bajraktari,Alina Kerimkulova,Gustavs Latkovskis,Omar Hamoui,Rimvydas Šlapikas,Laurent Visser,P. Dingli,Victoria Ivanov,Aneta Boskovic,Mbarek Nazzi,Frank L.J. Visseren,Irena Mitevska,Kjetil Retterstøl,Piotr Jankowski,Ricardo Fontes-Carvalho,Dan Gaita,Marat V. Ezhov,Marina Foscoli,Vojislav Giga,Daniel Pella,Zlatko Fras,L. Perez De Isla,Emil Hagström,Roger Lehmann,Leila Abid,Oner Ozdogan,Olena Mitchenko,Riyaz S. Patel,Stephan Windecker,Victor Aboyans,Jean-Philippe Collet,Veronica Dean,Donna Fitzsimons,Chris P Gale,Diederick E. Grobbee,Sigrun Halvorsen,Gerd Hindricks,Bernard Iung,Peter Jüni,Hugo A. Katus,Christophe Leclercq,Maddalena Lettino,Basil S. Lewis,Béla Merkely,Christian Mueller,Steffen E. Petersen,Anna Sonia Petronio,Marco Roffi,E. Shlyakhto,Iain A. Simpson,Miguel Sousa-Uva,Rhian M. Touyz +95 more
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.
Michelle L. O'Donoghue,Sergio Fazio,Robert P. Giugliano,Erik S.G. Stroes,Estella Kanevsky,Ioanna Gouni-Berthold,Kyung Ah Im,Armando Lira Pineda,Scott M. Wasserman,Richard Ceska,Marat V. Ezhov,J. Wouter Jukema,Henrik Jensen,S. Lale Tokgozoglu,François Mach,Kurt Huber,Peter S. Sever,Anthony C Keech,Terje R. Pedersen,Marc S. Sabatine +19 more